MPA & Vasculitis GuideANCA vasculitis, starting with MPA and kidney disease
Urgent symptoms: when to get help now

Call 911 (or your local emergency number) for severe or sudden trouble breathing, coughing up blood, or heavy or spurting bleeding from a dialysis access.

Contact your care team promptly for new visible blood in urine, much less urine than usual, rapidly worsening swelling, fever while taking immune-suppressing medicine, being unable to keep transplant medicines down, or cloudy peritoneal dialysis fluid.

Follow the emergency plan your treating center gave you. More on urgent symptoms

What is microscopic polyangiitis (MPA)?

MPA is a rare autoimmune disease. The immune system inflames small blood vessels, which can injure the organs those vessels feed.

Evidence reviewed Nov 2026

Every medical claim on this page links to its source. Last updated 15 November 2026. Educational information, not medical advice.

The short version

What is ANCA?

ANCA are antibodies aimed at proteins inside a type of white blood cell. Most people with MPA have a type called MPO-ANCA. Some have PR3-ANCA, and some test negative. Activated white blood cells and part of the immune system called complement help cause the vessel injury.2,3

What causes it?

In most people the trigger is unknown. Researchers study genetic susceptibility and environmental factors, but genes do not give a reliable personal prediction, and MPA does not follow a simple single-gene inheritance pattern.4,5 Some medicines, including hydralazine and propylthiouracil, can cause a similar illness, which is one reason your team reviews your medication list.2

How common is it?

MPA is rare. Estimates vary by country and by how studies define cases, so we do not quote a single number here.5

For researchers and clinicians

MPA is classified within AAV; KDIGO 2024 and the 2025 BSR recommendations frame management by ANCA specificity and organ involvement rather than by clinical label alone. MPO and PR3 disease differ in genetic associations; clinical diagnosis and antibody category can overlap.2,3,4

Next: What the diagnosis means · Your first 30 days

Sources

  1. Vasculitis Foundation: Microscopic polyangiitis (MPA) [doc ref 7]
  2. KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
  3. Rheumatology (2025): 2025 British Society for Rheumatology recommendations for ANCA-associated vasculitis [doc ref 40]
  4. EBioMedicine (2026): Exploration of the genetic architecture of ANCA-associated vasculitis [doc ref 33]
  5. Orphanet: Microscopic polyangiitis [doc ref 34]

Links checked 15 November 2026. Full list: all sources.